Where does Kite Pharma, Inc. rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), Kite Pharma, Inc. ranks #8,625 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does Kite Pharma, Inc. hold?

Kite Pharma, Inc. holds 37 US utility patents granted between 2018 and 2025, spanning 9 technology areas.

What is Kite Pharma, Inc.'s Innovation Score?

Kite Pharma, Inc. has an Innovation Score of 46.5 out of 100 (top 21% of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

What technology areas does Kite Pharma, Inc. focus on?

Kite Pharma, Inc.'s top technology area is C07K (Peptides) with 36 patents, ranking #266 of 3,615 assignees active in that subclass. Grants appear in 9 CPC subclasses total.

Is Kite Pharma, Inc.'s patent grant rate increasing or decreasing?

Kite Pharma, Inc.'s recent grant velocity is +800% compared to the prior five-year period (grant years, not application filing dates). This indicates accelerating grant output.

What does claim depth mean for Kite Pharma, Inc.'s patents?

Kite Pharma, Inc.'s patents average 17.8 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

How is the Kite Pharma, Inc. patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO 2015–2025 USPTO PatentsView US Corporation

Kite Pharma, Inc.

USPTO PatentsView assignee record - 37 granted patents across 9 technology areas, recorded in grant years 2018–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: C07K (Peptides).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, Kite ranks #8,625 of 49,997 tracked US assignees by granted-patent volume, with 37 patents across 9 technology areas.

#8,625
of 49,997 US assignees by volume: Top 21%
by Innovation Score (46.5/100): 17.8
avg claims per patent: +800%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R8625 · US Corporation #8,625 · 37 grants

GRANTS-SMALL · UPPER-Q · PHOTO-FINISH · CPC-NARROW · INNOV-PAR · CLAIMS-RICH · TYPE-USCORP · VEL-SURGE · BOOK-FULL

GRANTS-SMALL 37 grants
UPPER-Q #8,625/49,997
PHOTO-FINISH Kadtc Pet Supplies
CPC-NARROW C07K · 9 areas
INNOV-PAR 46.5/100
CLAIMS-RICH 17.8 claims/avg
TYPE-USCORP US Corporation
VEL-SURGE +800% vel
BOOK-FULL 10/10 fields

Nearest grant-volume peer: Kadtc Pet Supplies Inc (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How Kite’s 46.5 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Volume 12.6 pts (27%) Velocity 12.7 pts (27%) Breadth 10.6 pts (23%) Claim depth 10.7 pts (23%)

Qualcomm Incorporated · highest

85
Bedgear · near

47
Industrial Cooperati… · near

47
Innovative Logistics · near

47
Kite Pharma · this assignee

47
Nihon University · near

47
3D Lighting… · lowest

7

What this shows Kite's Innovation Score is 46.5/100 (top 21% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Does more volume mean deeper claims for Kite?

Each dot is one of Kite’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Kite’s own 17.8 claims/patent is ABOVE the 15.2 median for these volume peers. More thorough claims than most filers at this scale, not just more of them.

Kite vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where Kite's grants concentrate

Kite Pharma, Inc. is a focused PatentsView assignee: 9 CPC subclasses with 97.3% of grants classified under C07K (Peptides). Peak complete grant year is 2023 (8 grants) versus a trough of 1 in 2018. By volume, Kite sits between Kadtc Pet Supplies Inc and Lamplight Farms Incorporated.

Kite's three-year grant acceleration

Kite Pharma, Inc. shows 19 grants in 2022–2024 against only 10 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.

Kadtc Pet Supplies

37
Karyopharm Therap…

37
Ketra

37
Khalifa Universit…

37
Lensvector

37
Leoni Bordnetz-sy…

37
Liebherr-aerospac…

37
Lamplight Farms I…

37
Kite Pharma ◀

37

What this shows Kite holds 37 patents at rank #8,626, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near Kite

By rank, the assignees closest to #8,626 in granted patent volume.

Leaders in C07K (Peptides)

Other assignees with the most granted patents in Kite's primary technology class.

Assignees with similar portfolio profiles

Two PlainPatent-derived peer sets for Kite, neither rank-band nor same-CPC leaders (those blocks stay above). In C07K (Peptides), Kite ranks #266 of 3,615 assignees by patent count in that subclass.

Similar innovation score

Nearest assignees by Innovation Score (47 here).

Nihon University 47 Industrial Cooperation Foundation Chonbuk National University 47 Bedgear, LLC 47 Innovative Logistics, LLC 47

Kite's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

47 Top 21% higher than 79% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2018–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2018–2019 baseline. Full figures in the table below.

View data table

Kite Pharma, Inc. patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2018	1	2.7%
2019	2	5.4%
2020	6	16.2%
2021	2	5.4%
2022	5	13.5%
2023	8	21.6%
2024	6	16.2%
2025partial year	7	18.9%

Which technologies does Kite Pharma, Inc. patent most?

C07K - Peptides 36

A61K - Preparations FOR Medical, Dental OR Toiletry Purposes 36

A61P - Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations 28

C12N - Microorganisms OR ENZYMES; Compositions THEREOF; Propagating, Preserving, OR Maintaining MICROORGANISMS; Mutation OR Genetic ENGINEERING; Culture Media 22

G01N - Investigating OR Analysing Materials BY Determining Their Chemical OR Physical Properties 8

C12Q - Measuring OR Testing Processes Involving Enzymes, Nucleic Acids OR Microorganisms ; Compositions OR Test Papers THEREFOR; Processes OF Preparing Such COMPOSITIONS; Condition-responsive Control IN Microbiological OR Enzymological Processes 3

C12P - Fermentation OR Enzyme-using Processes TO Synthesise A Desired Chemical Compound OR Composition OR TO Separate Optical Isomers From A Racemic Mixture 2

Y02A - Technologies FOR Adaptation TO Climate Change 2

C07F - Acyclic, Carbocyclic OR Heterocyclic Compounds Containing Elements Other Than Carbon, Hydrogen, Halogen, Oxygen, Nitrogen, Sulfur, Selenium OR Tellurium 1

Top 9 of 9 technology areas

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

View all rankings → How is Innovation Score calculated?

What to do with this data

Kite Pharma, Inc.'s patent record in context - here's where to go next.

Kite Pharma, Inc.'s lead technology class is C07K (Peptides), 97.3% of its portfolio - see every assignee active in that class. Explore C07K
Ranked #8,625 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare Kite Pharma, Inc. against Kadtc Pet Supplies Inc, an assignee filing at a similar volume. Compare portfolios
Innovation Score of 46.5/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent, US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.